atomoxetine hydrochloride has been researched along with Anankastic Personality in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robbins, TW | 1 |
| Hogan, MK; Rao, NP | 1 |
| Cappelletti, S; Chetoni, C; Kotzalidis, GD; Pasquini, M; Piacentino, D; Sani, G | 1 |
| Akın, E; Demirkaya, M; Demirkaya, SK; Yusufoğlu, C | 1 |
| Geffken, GR; Goldstein, RB; Goodman, WK; Lehmkuhl, H; Murphy, TK; Storch, EA | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Acosta, MT; Castellanos, FX | 1 |
2 review(s) available for atomoxetine hydrochloride and Anankastic Personality
| Article | Year |
|---|---|
Cross-species studies of cognition relevant to drug discovery: a translational approach.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognition; Depression; Drug Discovery; Humans; Obsessive-Compulsive Disorder; Reaction Time; Selective Serotonin Reuptake Inhibitors; Translational Research, Biomedical | 2017 |
Pharmacotherapy for Hoarding Disorder: How did the Picture Change since its Excision from OCD?
Topics: Atomoxetine Hydrochloride; Hoarding Disorder; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2019 |
5 other study(ies) available for atomoxetine hydrochloride and Anankastic Personality
| Article | Year |
|---|---|
Case report: Cytochrome P450 implications for comorbid ADHD and OCD pharmacotherapy.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cytochromes; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder | 2017 |
Atomoxetine Use in Attention-Deficit/Hyperactivity Disorder and Comorbid Tic Disorder in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autoimmune Diseases; Child; Female; Humans; Male; Obsessive-Compulsive Disorder; Streptococcal Infections; Tic Disorders; Treatment Outcome | 2017 |
Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Propylamines; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 2009 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
[Tourette syndrome: an analysis of its comorbidity and specific treatment].
Topics: Adrenergic alpha-Agonists; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Guanfacine; Humans; Obsessive-Compulsive Disorder; Propylamines; Tourette Syndrome | 2004 |